Assessing the correlation between second progression-free survival (PFS2) and overall survival (OS) in advanced prostate cancer patients using medical data vision (MDV) claims database in Japan.

Masaki ShiotaRaf De MoorYosuke Koroki David Bin-Chia WuDavid Bin-Chia Wu

Published in: Current medical research and opinion (2022)

The results of this study indicate a significant correlation between PFS2 and OS, which adds additional evidence to the existing literature of using PFS2 as a surrogate endpoint for OS in patients with PC.

Keyphrases

free survival
prostate cancer
systematic review
health insurance
electronic health record
emergency department
adverse drug
benign prostatic hyperplasia